Drug Therapy of Parkinsonism
Drug Therapy of Parkinsonism
Drug Therapy of Parkinsonism
Parkinsonism
Dopamine
(oil)
Substantia nigra
(factory)
Mechanism of action
Adverse effects:
Restlessness, agitation, confusion, hallucination, toxic
psychosis, hypotension, urinary retention, peripheral
edema, dry mouth
a. Activates COMT
b. Decreases the formation of 3 OMD
c. Inhibits dopamine uptake
d. Inhibits MAO-B
3. A patient was administered levodopa for his
parkinsonism along with another drug which
reduces the peripheral adverse effects of levodopa.
Which one of the following drugs could have been
administered to reduce the peripheral adverse
effects of levodopa?
a. Amantadine
b. Carbidopa
c. Bromocriptine
d. Entacapone